Core Viewpoint - The company has approved a stock incentive plan that involves the allocation of 100,240 restricted shares to eligible employees, with specific performance and tenure conditions for vesting [1][11][16]. Summary by Sections Stock Incentive Plan Details - The total number of restricted shares to be allocated is 100,240, which represents 0.16% of the company's total share capital of 23,222.92 million shares [1]. - The initial grant consists of 295,500 shares, accounting for 0.13% of the total share capital, while 70,500 shares are reserved for future grants [1][2]. Eligibility and Performance Conditions - The incentive plan targets core technical and management personnel, with a total of 8 eligible individuals [2]. - The vesting schedule includes three phases: - 30% after 12 months - 30% after 24 months - 40% after 36 months [2][3]. - Performance assessment for the years 2022-2024 will determine the vesting ratio based on revenue growth and sales from overseas brand clients and third-generation products [2][3]. Performance Assessment Metrics - The performance metrics include: - Revenue growth rate targets of 50% for 2022, 80% for 2023, and 110% for 2024 [2][3]. - The formula for calculating the company performance score (X) is based on weighted contributions from various performance indicators [3]. - The vesting ratio (M) is determined by the performance score, with a maximum of 100% for scores above 100 and 0% for scores below 60 [3][12]. Approval and Compliance - The stock incentive plan has undergone necessary approvals from the board and independent directors, ensuring compliance with relevant regulations [4][15]. - The company has also conducted a review of the eligibility of the incentive recipients, confirming their compliance with legal and regulatory requirements [17][18]. Vesting and Stock Allocation - The first vesting period for the initial grant is set to begin on January 17, 2024, with a vesting price adjusted to 23.54 yuan per share [9][10]. - The total number of shares that have been granted but not yet vested has been adjusted to 541,680 shares, with specific allocations for both initial and reserved grants [7][10].

Core Viewpoint - The report outlines the independent financial advisory opinion regarding the 2024 restricted stock incentive plan of Hangzhou Aotai Biotechnology Co., Ltd, confirming that the plan has received necessary approvals and meets regulatory requirements [1][13]. Summary by Sections Definitions - The report defines key terms related to the incentive plan, including "independent financial advisor," "restricted stock," "grant date," and "vesting conditions," among others [1][2]. Approval Procedures - The company held several meetings to approve the incentive plan, including the third board meeting on September 2, 2024, and the second extraordinary shareholders' meeting on September 18, 2024, where the plan was reviewed and approved [4][5][6]. Grant Conditions - The report specifies that the grant of restricted stock is contingent upon the company and the incentive recipients meeting certain conditions, including no adverse audit opinions and compliance with relevant laws [6][11]. Grant Details - The grant date for the restricted stock is set for August 29, 2025, with a total of 188,000 shares to be granted, representing 0.24% of the company's total share capital, at a price of 26.2993 RMB per share [7][10]. Vesting Schedule - The vesting of the restricted stock will occur in two phases: 50% after 12 months and the remaining 50% after 24 months, with specific conditions outlined for each vesting period [8][9]. Performance Assessment - The performance assessment for the incentive plan will be based on revenue and product registration targets for the years 2025 and 2026, with specific thresholds set for both domestic and FDA product registrations [11]. Financial Impact - The report notes that the implementation of the incentive plan will be accounted for in accordance with relevant accounting standards, and shareholders are advised to consider potential dilution effects [13]. Conclusion - The independent financial advisor concludes that the incentive plan has met all necessary conditions and approvals, aligning with regulatory requirements and the company's governance framework [13].

证券代码：603258 证券简称：电魂网络 公告编号：2025-026 于公司<2024 年限制性股票激励计划（草案）>及其摘要的议案》 《关于公司<2024 杭州电魂网络科技股份有限公司 关于回购注销 2024 年限制性股票激励计划部分限制性股票 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 杭州电魂网络科技股份有限公司（以下简称"公司"）于 2025 年 8 月 28 日 召开第五届董事会第五次会议和第五届监事会第五次会议，审议通过《关于回购 注销 2024 年限制性股票激励计划部分限制性股票的议案》。鉴于公司 2024 年限 制性股票激励计划（以下简称"《激励计划（草案）》"或"本激励计划"）首 次授予和预留部分的 5 名激励对象因离职不再具备激励资格，公司对其持有的已 获授但尚未解除限售的限制性股票合计 119,000 股予以回购注销。该事项已得到 一、已履行的决策程序和信息披露情况 通过了《关于公司<2024 年限制性股票激励计划（草案）>及其摘要的议案》《关 于公司<2024 年限制性股票激励计划实 ...

Core Viewpoint - Jiangsu Tiannai Technology Co., Ltd. has announced the cancellation of 30,592 shares of unvested restricted stock as part of its 2022 Restricted Stock Incentive Plan, which will not materially affect the company's financial status or operational results [1][9]. Summary by Sections Company Stock Incentive Plan - The company held its second board meeting on June 24, 2022, where it approved the 2022 Restricted Stock Incentive Plan and related management measures [2]. - The company’s supervisory board also approved the plan and the list of initial grant recipients [3]. - The plan was publicly disclosed on June 25, 2022, and no objections were raised during the internal announcement period [4]. Adjustments and Approvals - On July 15, 2022, the company’s first extraordinary general meeting approved the incentive plan, granting the board authority to determine the grant date and manage related matters [5]. - The board and supervisory board meetings on July 16, 2022, confirmed the first grant of restricted stock to the incentive recipients [6]. - On July 13, 2023, the board approved adjustments to the grant price and the total number of unvested restricted stocks [7]. Cancellation of Restricted Stocks - The board meeting on August 29, 2023, approved the cancellation of certain restricted stocks that did not meet vesting conditions [8]. - The total number of restricted stocks canceled amounts to 30,592 shares due to various reasons, including non-vesting conditions [9]. Impact and Legal Opinions - The cancellation of restricted stocks is not expected to impact the company's financial condition or management stability [9]. - The board's compensation and assessment committee confirmed that the cancellation complies with relevant laws and regulations [10].

Group 1 - The core viewpoint of the article is that Hangzhou Aotai Biotechnology Co., Ltd. has conducted a review of the list of incentive objects for its 2024 restricted stock incentive plan and has confirmed their eligibility according to relevant laws and regulations [1][2] - The incentive objects do not include independent directors, supervisors, shareholders holding more than 5% of the company's shares, actual controllers and their immediate family members, or foreign employees [1][2] - The list of incentive objects for the plan is consistent with the list approved at the company's second extraordinary general meeting in 2024 [1][2] Group 2 - The incentive objects meet the qualifications stipulated by the Company Law, Securities Law, and other relevant regulations, confirming their legal and effective status as incentive recipients [2] - The reserved grant date for the incentive plan is set for August 29, 2025, with a grant price of 26.2993 yuan per share for 188,000 restricted shares to be awarded to 41 eligible incentive objects [2]

Core Points - The company has announced the reserved grant of 188,000 restricted stocks under the 2024 Restricted Stock Incentive Plan, with a grant date set for August 29, 2025 [1][2][16] - The grant price for the restricted stocks has been adjusted from 29.24 yuan per share to 26.2993 yuan per share [5][16] - The incentive plan aims to enhance employee cohesion and operational efficiency, potentially leading to improved business performance [18] Summary by Sections Incentive Plan Overview - The 2024 Restricted Stock Incentive Plan has been approved, and the reserved grant conditions have been met [2][16] - A total of 41 individuals will receive the reserved stocks, which represent approximately 0.24% of the company's total share capital [11][16] Grant Conditions and Procedures - The decision-making process for the stock grant has been completed, including necessary disclosures and approvals from the board and supervisory committee [3][4][16] - The company has confirmed that no disqualifying conditions exist for the incentive recipients, ensuring compliance with relevant laws and regulations [6][16] Performance Metrics - The performance assessment for the incentive plan will be conducted over two fiscal years, with specific revenue and product registration targets set for each vesting period [12][15] - The first vesting period requires a revenue target of 1.05 billion yuan, while the second period requires a target of 1.26 billion yuan [12] Accounting and Financial Impact - The fair value of the restricted stocks will be calculated using the Black-Scholes model, and the associated costs will be amortized over the vesting period [18] - The implementation of the incentive plan is expected to have a positive impact on the company's operational performance and internal value [18]

Core Viewpoint - The company has adjusted the grant price of its 2024 restricted stock incentive plan from 29.24 CNY per share to 26.2993 CNY per share due to the implementation of its profit distribution plan [1][5][6] Group 1: Adjustment Details - The adjustment of the grant price was approved by the company's board and supervisory board during their respective meetings [1][2] - The adjustment was made in accordance with the company's 2024 restricted stock incentive plan and the authorization from the second extraordinary general meeting of shareholders [1][5] - The adjusted grant price reflects the cash dividends distributed to shareholders, calculated as follows: P = P0 - V, where P0 is the original grant price and V is the cash dividend per share [4][5] Group 2: Financial Impact - The adjustment of the grant price is not expected to have a substantial impact on the company's financial condition or operating results [5][6] - The adjustment will not affect the stability of the management team or the continued implementation of the incentive plan [5][6] Group 3: Opinions from Supervisory and Compensation Committees - The supervisory board agrees that the adjustment complies with relevant laws and regulations and does not harm the interests of the company and all shareholders [5][6] - The compensation and assessment committee of the board also supports the adjustment, confirming its compliance with the management regulations and the incentive plan [6]

Core Viewpoint - The legal opinion letter from Beijing Zhonglun Law Firm addresses the adjustments to the grant price, the achievement of the vesting conditions for the third vesting period of the 2022 Restricted Stock Incentive Plan, and the cancellation of certain unvested restricted stocks for Jiangsu Tiannai Technology Co., Ltd. [1][23] Summary by Sections Grant Price Adjustment - The grant price for the restricted stocks under the 2022 incentive plan has been adjusted from 23.24 CNY per share to approximately 23.09 CNY per share due to a cash dividend distribution plan approved at the 2024 annual general meeting [13][15]. - The adjustment method follows the formula: P = P0 - V, where P0 is the original grant price and V is the cash dividend per share [15]. Vesting Conditions Achievement - The third vesting period for the first grant of restricted stocks is set from August 4, 2025, to July 31, 2026 [16]. - The vesting conditions include the absence of negative audit opinions and the fulfillment of performance targets related to revenue growth and sales from overseas brand customers [19][23]. - The company achieved a revenue of approximately 1.45 billion CNY for 2024, reflecting a 9.71% increase compared to 2021, and a significant increase of 829.07% in sales from overseas brand customers [19]. Cancellation of Restricted Stocks - A total of 30,592 shares of restricted stocks that were granted but not vested will be canceled according to the provisions of the 2022 incentive plan [23]. - The cancellation is in compliance with the relevant regulations and the company's internal policies [23].

Group 1 - The company has not distributed cash dividends, issued bonus shares, or increased capital from reserves during the reporting period [3] - The company did not experience any changes in its controlling shareholder or actual controller during the reporting period [5] - The company has approved the cancellation of unvested restricted stock from the 2024 incentive plan and the expiration of reserved rights [5][6] Group 2 - The company held board meetings to review and approve the 2025 restricted stock incentive plan and its management measures [6] - The relevant proposals regarding the 2025 incentive plan were approved at the 2024 annual general meeting [6]

登录新浪财经APP 搜索【信披】查看更多考评等级 公司代码：688312 公司简称：燕麦科技 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到www.sse.com.cn网站仔细阅读半年度报告全文。 1.2重大风险提示 公司已在本报告中描述公司面临的风险，敬请查阅本报告第三节"管理层讨论与分析"中"五、风险因 素"相关内容，请投资者予以关注。 1.3本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.4公司全体董事出席董事会会议。 1.5本半年度报告未经审计。 1.6董事会决议通过的本报告期利润分配预案或公积金转增股本预案 不适用 □适用 √不适用 第二节 公司基本情况 2.1公司简介 公司股票简况 ■ 公司存托凭证简况 □适用 √不适用 联系人和联系方式 ■ 2.2主要财务数据 1.7是否存在公司治理特殊安排等重要事项 单位：元 币种：人民币 ■ 2.3前10名股东持股情况表 单位: 股 ■ 2.4前十名境内存托凭证持有人情况表 □适 ...